Molecular Genetics and Clinical Diagnosis of Rare Diseases

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Molecular Genetics and Genomics".

Deadline for manuscript submissions: 10 June 2024 | Viewed by 1020

Special Issue Editor

Division of Genomic Medicine, Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Keck School of Medicine of USC, Los Angeles, CA 90027, USA
Interests: rare mendelian diseases; molecular genetics; clinical diagnosis
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Advances in sequencing technologies have improved genetic diagnosis by enhancing the diagnostic yield, decreasing the time required to reach a diagnosis, and lowering the cost to patients and healthcare systems. Over the past decade, next-generation sequencing (NGS)-based disease-specific multi-gene panel, exome, and whole-genome sequencing have proven powerful in the diagnosis of patients with rare clinical conditions. In particular, the discovery of novel disease-associated genes has augmented our knowledge of the genetic etiologies of numerous previously undiagnosed human diseases, thus advancing our understanding of disease mechanisms and making it possible to develop potential treatments for these diseases.

In this Special Issue, we welcome original articles and reviews covering aspects of new disease genes, novel methodologies for diagnosing rare genetic disorders, and the potential treatment of genetic diseases. These include, but are not limited to, studies related to novel disease gene discoveries, expanded disease phenotypes, the disease–gene relationship, novel disease mechanisms, treatments, and outcomes. We also welcome studies on methodologies relevant to the diagnosis of rare genetic disorders (lab approaches, functional studies, animal models, bioinformatics and artificial intelligence, causal analyses, and others).

Dr. Miao Sun
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nucleotide DNA
  • mitochondrial DNA
  • human disease
  • mendelian diseases
  • copy number variation
  • molecular genetics
  • chromosome abnormality
  • genetic genealogy
  • epigenetics
  • causal analyses
  • bioinformatics
  • animal models
  • functional studies

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

8 pages, 752 KiB  
Case Report
Therapeutic Management and Outcomes of Hepatoblastoma in a Pediatric Patient with Mosaic Edwards Syndrome
by Patrycja Sosnowska-Sienkiewicz, Alicja Kamińska, Iwona Anderko, Gabriela Telman-Kołodziejczyk, Przemysław Mańkowski and Danuta Januszkiewicz-Lewandowska
Genes 2024, 15(4), 463; https://doi.org/10.3390/genes15040463 - 7 Apr 2024
Viewed by 808
Abstract
The mosaic form of Edwards syndrome affects 5% of all children with Edwards syndrome. The clinical phenotype is highly variable, ranging from the full spectrum of trisomy 18 to the normal phenotype. The purpose of this publication was to present the therapeutic process [...] Read more.
The mosaic form of Edwards syndrome affects 5% of all children with Edwards syndrome. The clinical phenotype is highly variable, ranging from the full spectrum of trisomy 18 to the normal phenotype. The purpose of this publication was to present the therapeutic process in an 18-month-old girl with the mosaic form of Edwards syndrome and hepatoblastoma, against the background of other cases of simultaneous occurrence of this syndrome and hepatoblastoma described so far. It appears that this particular group of patients with hepatoblastoma and Edwards syndrome can have good outcomes, provided they do not have life-threatening cardiac or other severe defects. Due to the prematurity of our patient and the defects associated with Edwards syndrome, the child required constant multidisciplinary care, but Edwards syndrome itself was not a reason to discontinue therapy for a malignant neoplasm of the liver. Regular abdominal ultrasound examination, along with AFP testing, may be helpful in the early detection of liver tumors in children with Edwards syndrome Full article
(This article belongs to the Special Issue Molecular Genetics and Clinical Diagnosis of Rare Diseases)
Show Figures

Figure 1

Back to TopTop